Robert Blaustein insider trades
Open-market stock purchases and sales by Robert Blaustein, Chief Development Officer at Edgewise Therapeutics, Inc, from SEC Form 4 filings since Jan 21, 2025.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- EWTX Edgewise Therapeutics, Inc: other filings, last Aug 12, 2025